STSS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
STSS is not a good buy right now for an impatient investor. The trend remains decisively bearish (SMA_200 > SMA_20 > SMA_5), price is pressing key support around ~2.06, and the probabilistic pattern outlook is negative over the next day/week/month. Options positioning is mildly call-leaning by open interest, but volume is thin and not providing strong bullish confirmation. With no near-term news catalysts and weak/unstable fundamentals (tiny revenue base and very large losses), the risk/reward favors avoiding new entries at this moment.
Price/Trend: Bearish structure with moving averages stacked downward (SMA_200 > SMA_20 > SMA_5), signaling a prevailing downtrend. Momentum: MACD histogram is positive (0.0238) but contracting—this suggests upside momentum is fading rather than strengthening. RSI: RSI_6 at ~39.9 is below the midpoint and leaning weak (not oversold enough to imply a high-conviction bounce). Levels: Post-market ~2.05 is sitting on/just under S1 (2.056). If 2.056 fails, next support is S2 (1.967). Upside resistance starts at Pivot (2.201) then R1 (2.347). Quant-style pattern read: Similar-pattern projection implies downside bias (60% chance of -0.49% next day, -0.92% next week, -3.08% next month), reinforcing the bearish setup.
Intellectia Proprietary Trading Signals: Intellectia Proprietary Trading Signals
OI skew slightly favors calls (put/call OI 0.54), which can be interpreted as modestly bullish positioning.
MACD histogram is still above zero, implying some residual positive momentum versus a fully bearish momentum state.
Price is near support (2.056), where short-term technical bounces can occur if support holds.
No news in the last week—no visible event-driven catalyst to reverse sentiment.
Latest quarter: 2025/Q3. Revenue: $2,289,045 (reported as +0.00% YoY), indicating essentially no growth from a very small base. Profitability: Net income was -$105,333,293 (a very large loss). EPS was -4.33 (down -98.86% YoY), indicating severe earnings deterioration. Margins: Gross margin ~45.25% (reported flat YoY), but the scale of losses implies operating/other costs dominate. Overall: The quarter does not show improving business momentum or profitability that would support an impatient “buy now” decision.
No analyst rating changes or price target updates were provided in the data, implying limited/unclear Street sponsorship. Wall Street-style pros/cons based on available info: Pros—possible technical bounce near support and slightly call-leaning OI. Cons—dominant bearish trend, lack of catalysts, and weak financial profile with large losses; these cons outweigh the pros for a near-term buy.
